Claims for Patent: 9,186,380

Summary for Patent: 9,186,380

Title:	Minced cartilage systems and methods
Abstract:	Compositions comprising a plurality of cartilage particles from a human adult cadaveric donor, wherein the cartilage particles comprise viable chondrocytes, and a biocompatible carrier are provided. Methods of manufacturing cartilage compositions comprising a plurality of cartilage particles from a human adult cadaveric donor are also provided.
Inventor(s):	Shi; Yaling (Larkspur, CO), Barrett; Carolyn (Denver, CO)
Assignee:	AlloSource (Centennial, CO)
Application Number:	14/081,913
Patent Claims:	1. A method of manufacturing a cartilage composition, the method comprising: obtaining cartilage tissue from a human adult cadaveric donor age 15 years or older; mincing the cartilage tissue into a plurality of cartilage particles having an average volume from about 1 mm.sup.3 to about 30 mm.sup.3 using a laser cutter at a power of about 3 Watts to about 13.5 Watts and a frequency of about 400 Hz to about 2400 Hz, wherein the cartilage particles comprise chondrocytes native to the cartilage tissue, and wherein at least 50% of the chondrocytes present in the plurality of cartilage particles are viable; suspending the plurality of cartilage particles in a biocompatible carrier; and packaging the suspended plurality of cartilage particles into a container. 2. The method of claim 1, wherein the cartilage tissue is articular cartilage tissue. 3. The method of claim 1, wherein the cartilage tissue is from a human donor that is 18 years of age or older at the time of donation. 4. The method of claim 1, wherein prior to the mincing step, the cartilage tissue is sliced to a thickness of about 0.25 mm to about 5 mm. 5. The method of claim 1, wherein the mincing step comprises cutting the cartilage tissue with a laser cutter, with a mechanical blade, or with a mechanical press. 6. The method of claim 1, wherein the cartilage tissue is minced into a plurality of cartilage particles having an average width from about 1 mm to about 5 mm. 7. The method of claim 1, wherein the cartilage tissue is minced into a plurality of cartilage particles having an average diameter from about 1 mm to about 5 mm. 8. The method of claim 1, wherein following the mincing step, the plurality of cartilage particles are washed with a saline solution. 9. The method of claim 1, wherein the biocompatible carrier comprises a cryopreservation medium. 10. The method of claim 1, wherein prior to the suspending step, the method further comprises combining the plurality of cartilage particles with a biological adhesive. 11. The method of claim 1, wherein prior to the suspending step, the method further comprises combining the plurality of cartilage particles with demineralized bone. 12. The method of claim 1, wherein prior to the suspending step, the method further comprises combining the plurality of cartilage particles with a bone or cartilage substrate seeded with stem cells. 13. The method of claim 1, wherein the plurality of cartilage particles comprise at least 50,000 viable cells per cm.sup.3. 14. The method of claim 1, wherein the biocompatible carrier comprises one or more cryoprotective agents, selected from the group consisting of glycerol, DMSO, hydroxyethyl starch, polyethylene glycol, propanediol, ethylene glycol, butanediol, polyvinylpyrrolidone, and alginate. 15. The method of claim 1, wherein the biocompatible carrier comprises a growth medium. 16. The method of claim 1, wherein the plurality of cartilage particles are in the shape of circles, spheres, squares, rectangles, cubes, cylinders, strips, sheets, ribbons, Zig-Zag shapes, or accordion shapes. 17. The method of claim 1, wherein prior to the suspending step, the method further comprises treating the plurality of cartilage particles with one or more enzymes that promote the release of chondrocyte cells from cartilage particles. 18. The method of claim 17, wherein the one or enzymes comprise at least one of collagenase or pronase.

Details for Patent 9,186,380

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2032-11-15